Single‐Agent Regorafenib in Metastatic Colorectal Cancer...

  • Main
  • 2018 / 08
  • Single‐Agent Regorafenib in Metastatic Colorectal Cancer...

Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)

García‐Alfonso, Pilar, Benavides, Manuel, Falcó, Esther, Muñoz, Andrés, Gómez, Auxiliadora, Sastre, Javier, Rivera, Fernando, Montagut, Clara, Salgado, Mercedes, López‐Ladrón, Amelia, López, Rafael, R
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2018-0316
Date:
August, 2018
File:
PDF, 278 KB
english, 2018
Conversion to is in progress
Conversion to is failed